申请人:Astra Pharmaceuticals Limited
公开号:US05929100A1
公开(公告)日:1999-07-27
Compounds of formula I, ##STR1## wherein X represents naphthyl optionally substituted by alkyl or halogen; and p, q and r independently represent 2 or 3, and pharmaceutically acceptable salts thereof; processes for their preparation and methods for their use.
式I的化合物,其中X代表萘基,可选择性地被烷基或卤素取代; p、q和r分别独立地表示2或3,以及其药学上可接受的盐; 用于它们的制备过程和方法。